Want to join the conversation?
$MYL announced the U.S. launch of Metformin Hydrochloride Extended-release Tablets, generic version of Watson's Fortamet. $MYL received final approval from the U.S. Food and Drug Administration (FDA) for Abbreviated New Drug Application (ANDA) for this product that is indicated to improve glycemic control in adults with type 2 diabetes mellitus.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)